Jan Nolta, Director of the Stem Cell Program and Gene Therapy Center at University of California, Davis, shared a post on LinkedIn:
“I’m excited to share that our team at the UC Davis Institute for Regenerative Cures has entered into a strategic partnership with Thermo Fisher Scientific to expand access to cell, gene, and advanced therapies. Through this collaboration, we will introduce new manufacturing technologies for cell therapies and help build the ecosystem and infrastructure needed to serve our patients across 33 counties in Northern California, from Central CA to the Oregon border.
We are proud to be part of the growing advanced therapies ecosystem and, together with Thermo Fisher Scientific, to help build the capabilities needed to reach and impact patients who need these therapies most. Stay tuned for more updates on this exciting partnership!”
More posts featuring Jan Nolta